Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.44
Delayed Data
As of Jul 02
 -0.03 / -0.67%
Today’s Change
3.26
Today|||52-Week Range
6.28
+27.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovery, development and commercialization of drugs in the therapeutic areas such as cardiovascular, central nervous system, inflammatory and metabolic diseases. Its product pipeline includes Lorcaserin, APD334, APD371, temanogrel and nelotanserin. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Contact Information

Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego California 92121
P:(858) 453-7200
Investor Relations:
185845372001347

Employees

Shareholders

Individual stakeholders4.43%
Mutual fund holders32.64%
Other institutional25.75%

Top Executives

Jack LiefChairman, President & Chief Executive Officer
Craig M. AudetSVP-Operations & Head-Global Regulatory Affairs
Robert E. HoffmanChief Financial Officer & Senior Vice President
Dominic P. BehanChief Scientific Officer, Executive Director & EVP
William R. ShanahanChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account